You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 37, 29-30 August 2002
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
CMEC confirms that the draft Minutes of its previous meeting (CMEC 36, 26 July 2002), as amended, are a true and accurate record of that previous meeting.
Item 5.2 Folic acid dissolution requirement
CMEC recommends to the TGA that:
- All tablets containing 400 micrograms or more of folic acid should comply with the proposed dissolution requirements by 25 November 2002 and publicity be directed to health professionals and information be posted on the TGA website advising that products containing 400 micrograms or more of folic acid must comply with these requirements; and
- All folic acid tablets containing between 100 and 400 micrograms of folic acid must comply with the proposed dissolution requirement, by 25 November 2003, or by a date to be negotiated with the industry.
Item 6.1 Magnesium phosphate dibasic trihydrate
CMEC recommends to the TGA that magnesium phosphate dibasic trihydrate is suitable for use as an ingredient in listable therapeutic medicines.
|CMEC 37 Extracted ratified minutes (pdf)||68KB|